Old Web
English
Sign In
Acemap
>
authorDetail
>
Daniel Olive
Daniel Olive
Boston Children's Hospital
Medicine
Pathology
Rhabdomyosarcoma
Surgery
Oncology
5
Papers
131
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Treatment of rhabdomyosarcoma and other malignant mesenchymal tumours of childhood with ifosfamide + vincristine + dactinomycin (IVA) as front-line therapy (a SIOP study).
1989
Cancer Chemotherapy and Pharmacology
J.J. Otten
F. Flamant
C Rodary
M. Brunat-Mentigny
L. Dutou
Daniel Olive
E. Quintana
Paul A. Voute
Show All
Source
Cite
Save
Citations (9)
Prognostic Factors in 281 Children with Nonmetastatic Rhabdomyosarcoma (RMS) at Diagnosis
1988
The Journal of Urology
C Rodary
Annie Rey
Daniel Olive
F. Flamant
E. Quintana
M. Brunat-Mentigny
Jacques Otten
Paul A. Voûte
Show All
Source
Cite
Save
Citations (0)
Prognostic factors in 281 children with nonmetastatic rhabdomyosarcoma (RMS) at diagnosis
1988
Medical and Pediatric Oncology
C Rodary
Annie Rey
Daniel Olive
Françoise F. Flamant
Erica E. Quintana
M. Brunat-Mentigny
Jacques Otten
Paul A. Voûte
Show All
Source
Cite
Save
Citations (56)
Efficacy of “8 drugs in 1 day” regimen in the treatment of poor risk childhood brain tumors
1985
Pediatric Hematology and Oncology
Daniel Olive
J. M. Zucker
M. Brunat
E. Quintana
Show All
Source
Cite
Save
Citations (6)
Paraaortic lymphadenectomy is not necessary in the treatment of localized paratesticular rhabdomyosarcoma
1984
Cancer
Daniel Olive
F. Flamant
J. M. Zucker
Paul A. Voûte
Maud Brunat‐Mentigny
Jacques Otten
L. Dutou
Show All
Source
Cite
Save
Citations (60)
1